Vedame Oils LLC dba UMA Oils FDA Warning (2017)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on July 18, 2017
Executive Summary
The FDA issued a warning letter to Vedame Oils LLC dba UMA Oils on July 18, 2017 citing regulatory violations. The letter was issued by Los Angeles District Office.
Detailed Analysis
False Claims and Regulatory Violations
“Use this treatment at the first sign of a blemish, as it is very effective at every stage — even on blemishes that have not fully surfaced.”
Potential Health Risks
Consumers should be aware of potential risks associated with products from Vedame Oils LLC dba UMA Oils.
Regulatory Context
“[P]atchouli essential oil [(an ingredient in this product)] relieves inflammation and combats bacteria.”
“Powerful anti-inflammatory and anti-bacterial agents combat redness...”
“Natural antibacterial agents like turmeric, clove and neem [(ingredients in this product)] destroy acne-causing bacteria…”
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Vedame Oils LLC dba UMA Oils?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are Vedame Oils LLC dba UMA Oils products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used Vedame Oils LLC dba UMA Oils products?
- If you have used products from Vedame Oils LLC dba UMA Oils and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter